Dutch media company VNU NV said Monday it will acquire US-based health care data provider IMS Health Inc. for around $7 billion in cash and stock.
NPPA seeks data from firms to revalidate existing prices.
.jpg)
The Drug (Prices Control) Order implemented in May last year brought into its purview 652 packs of 348 formulations.
An insider said that over the past decade or so Cipla has become immune to the exits of leaders. There have been no directional change in the long-term strategies.
Alkem Labs was issued drug alerts twice last year -- in June and July -- for its drug Glimekem.
It is the generic version of Teva Women's Health's Seasonale tablets
Govt bans brands with annual sales worth Rs 3,728 crore.
.jpg)
The company has launched the Decitabine for injection in the strength of 50 mg in the US market following approval by the United States Food & Drug Administration of Dr Reddy's abbreviated new drug applications, it said in a statement.
Sales growth of generics drugs has dropped to 3.6 per cent in the 12 months ended September 2008 compared with 11.4 per cent growth a year earlier, according to the latest report of IMS Health, the leading provider of market intelligence to the global pharmaceutical and healthcare industries. However, sales by volume increased by 5.4 per cent in the US, reflecting declining prices and fewer blockbusters losing patent protection in 2008.
Stiff competition in a highly fragmented market has led the domestic drug makers to depend on brand extensions rather than new product launches to corner a market share. A market intelligence study, organised by prescription audit company ORG IMS Health, has found that one in every three brands launched in the country is a brand extension. Such products comprise 18 per cent of the Rs 28,000-crore domestic pharmaceutical market.
Sunovion Pharmaceuticals Inc is the owner of the Eszopiclone drug.
Riluzole is indicated for the treatment of amyotrophic lateral sclerosis.
With global market research biggies like IMS Health and Ipsos already offshoring work to Indian third party companies and others like AC Nielsen all set to invest in a captive unit here, market research is tipped to be the next hot BPO opportunity.
Glenmark Generics Inc USA, the subsidiary of Glenmark Generics Ltd has received nod for it's Hydrocortisone Butyrate Cream USP (0.1 per cent), abbreviated new drug approval from the United States Food and Drug Administration, Glenmark Pharmaceuticals said in a statement.
To ensure equal access to health care, the government must consider it in a holistic manner and improve all parameters.
Drug major Novartis has been slapped with a Rs 300-crore penalty by drug regulator NPPA for overcharging consumers on sale of Voveran, its best-selling painkiller medicine.
The lowest drug prices were found in India and South Africa.
Popular antacid Mucaine Gel, manufactured by Pfizer's subsidiary Wyeth Laboratories, was also found laced with the heavy metals as well as cadmium.
Apart from Wockhardt, only Biocon manufactures insulin analog indigenously.
The latest price revision includes mostly cardiovascular drugs, anti-bacterials, anti-herpes, contraceptives and gastrointestinal medicines
The NPPA letter was issued to GSK on Wednesday.
India battles big pharma over cough syrup abuse, reducing supplies
Experts say despite it being a global deal, the transaction will have to undergo CCI scrutiny because of the scale of operations.
And when an inspector asked about the contents of unlabelled vials in the laboratory glassware washing area, a plant worker dumped them down a sink and said the contents could not be determined, according to a July 18 letter from the US Food and Drug Administration to Wockhardt, which makes sterile injectable drugs and various forms of insulin.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances